Table of Content

1. Introduction
1.1. Market Definition And Scope
1.2. Market Ecosystem
1.3. Currency And Limitations
1.4. Key Stakeholders

2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection And Validation
2.2.1. Secondary Research
2.2.2. Primary Research / Interviews With Key Opinion Leaders of The Industry
2.3. Market Sizing And Forecast
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.4. Assumptions For The Study

3. Executive Summary

4. Market Insights
4.1. Overview
4.2. Factors Affecting Market Growth
4.2.1. Impact Analysis of Market Dynamics
4.2.2. Factor Analysis
4.3. Remote Patient Monitoring Market: Regulatory Analysis
4.3.1. Overview
4.3.2. North America
4.3.2.1. U.S.
4.3.2.2. Canada
4.3.3. Europe
4.3.4. Asia-Pacific
4.3.4.1. China
4.3.4.2. Japan
4.3.4.3. India
4.3.5. Latin America
4.3.6. Middle East
4.4. Pricing Analysis
4.5. Industry Trends
4.5.1. Shift From Physician-Driven to Consumer-Driven Healthcare
4.5.2. Integration of Artificial Intelligence With Remote Patient Monitoring Technologies
4.6. Porter’s Five Forces Analysis
4.6.1. Bargaining Power of Buyers
4.6.2. Bargaining Power of Suppliers
4.6.3. Threat of Substitutes
4.6.4. Threat of New Entrants
4.6.5. Degree of Competition

5. Remote Patient Monitoring Market Assessment? by Product
5.1. Overview
5.2. Monitoring Devices
5.2.1. Monitoring Devices, by Functionality
5.2.1.1. Blood Glucose Monitoring Devices
5.2.1.2. Cardiac Monitoring Devices
5.2.1.3. Neurological Monitoring Devices
5.2.1.4. Respiratory Monitoring Devices
5.2.1.5. Multiparameter Monitoring Devices
5.2.1.6. Blood Pressure Monitoring Devices
5.2.1.7. Fetal And Neonatal Monitoring Devices
5.2.1.8. Weight Monitoring Devices
5.2.1.9. Other Monitoring Devices
5.2.2. Monitoring Devices, by Type
5.2.2.1. Wearable Monitoring Devices
5.2.2.2. Portable Monitoring Devices
5.2.2.3. Bench-Top Monitoring Devices
5.3. Software
5.4. Services

6. Remote Patient Monitoring Market Assessment?by Application
6.1. Overview
6.2. Diabetes
6.3. Cardiovascular Diseases
6.4. Neurological Disorders
6.5. Respiratory Diseases
6.6. Oncology
6.7. Other Applications

7. Remote Patient Monitoring Market Assessment?by End User
7.1. Overview
7.2. Home-Care Settings
7.3. Long-Term Care Facilities
7.4. Hospitals
7.5. Other End Users

8. Remote Patient Monitoring Market Assessment–by Geography
8.1. Overview
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.3. Europe
8.3.1. Germany
8.3.2. U.K.
8.3.3. France
8.3.4. Italy
8.3.5. Spain
8.3.6. Rest of Europe
8.4. Asia-Pacific
8.4.1. China
8.4.2. Japan
8.4.3. India
8.4.4. Rest of Asia-Pacific
8.5. Latin America
8.6. Middle East & Africa

9. Competition Analysis
9.1. Overview
9.2. Key Growth Strategies
9.3. Competitive Benchmarking
9.4. Competitive Dashboard
9.4.1. Industry Leaders
9.4.2. Market Differentiators
9.4.3. Vanguards
9.4.4. Emerging Companies

10. Company Profiles
10.1. Medtronic plc
10.2. Koninklijke Philips N.V.
10.3. Omron Corporation
10.4. Boston Scientific Corporation
10.5. Abbott Laboratories
10.6. Siemens Healthineers AG
10.7. Ge Healthcare Technologies, Inc.
10.8. F. Hoffmann-La Roche AG
10.9. Baxter International Inc.
10.10. Oracle Corporation
10.11. Dexcom, Inc.
10.12. VitalConnect, Inc.
10.13. Other Companies

11. Appendix
11.1. Available Customization
11.2. Related Reports



List of Figures

Figure 1 Research Process
Figure 2 Secondary Sources Referenced for This Study
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply Side & Demand Side)
Figure 6 Market Sizing and Growth Forecast Approach
Figure 7 Global Remote Patient Monitoring Market Size, by Product, 2024 Vs. 2031 (USD Million)
Figure 8 Global Remote Patient Monitoring Market Size, by Application, 2024 Vs. 2031 (USD Million)
Figure 9 Global Remote Patient Monitoring Market Size, by End User, 2024 Vs. 2031 (USD Million)
Figure 10 Remote Patient Monitoring Market, by Geography
Figure 11 Impact Analysis of Market Dynamics
Figure 12 Global Estimated Number of New Cancer Cases, 2020–2040
Figure 13 Benefits of Remote Patient Monitoring
Figure 14 Global Prevalence of Diabetes in People Aged 20-79 Years, 2011–2045
Figure 15 USFDA Regulatory Pathways For Medical Devices
Figure 16 Eu Regulatory Pathway - IVDR 2017/746
Figure 17 China: Medical Device Classification And Pre-Market Requirements For IVD Devices
Figure 18 Advantages of AI Integration in Remote Patient Monitoring
Figure 19 Porter’s Five Forces Analysis
Figure 20 Global Remote Patient Monitoring Market, by Product, 2024 Vs. 2031 (USD Million)
Figure 21 Global Remote Patient Monitoring Market, by Application, 2024 Vs. 2031 (USD Million)
Figure 22 Estimated Number of Cancer Cases (2020-2040)
Figure 23 Global Remote Patient Monitoring Market, by End User, 2024 Vs. 2031 (USD Million)
Figure 24 Global Remote Patient Monitoring Market, by Geography, 2024 Vs. 2031 (USD Million)
Figure 25 North America: Remote Patient Monitoring Market Snapshot
Figure 26 Geriatric Population in Canada (2019–2050)
Figure 27 Europe: Remote Patient Monitoring Market Snapshot
Figure 28 Asia-Pacific: Remote Patient Monitoring Market Snapshot
Figure 29 China: Estimated Number of New Cancer Cases (2020–2040)
Figure 30 Japan: Percentage of Population Aged 65 And Above (2010-2030)
Figure 31 Key Growth Strategies Adopted by Leading Players, 2020-2023
Figure 32 Remote Patient Monitoring Market: Competitive Benchmarking by Region
Figure 33 Competitive Dashboard: Remote Patient Monitoring Market
Figure 34 Medtronic plc: Financial Overview (2022)
Figure 35 Koninklijke Philips N.V.: Financial Overview (2022)
Figure 36 OMRON Corporation: Financial Overview (2022)
Figure 37 Boston Scientific Corporation: Financial Overview (2022)
Figure 38 Abbott Laboratories: Financial Overview (2022)
Figure 39 Siemens Healthineers AG: Financial Overview (2022)
Figure 40 GE Healthcare Technologies, Inc.: Financial Overview (2023)
Figure 41 F. Hoffmann-La Roche AG: Financial Overview (2023)
Figure 42 Baxter International, Inc.: Financial Overview (2023)
Figure 43 Oracle Corporation: Financial Overview (2022)
Figure 44 DexCom, Inc.: Financial Overview (2023)